⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

March 18, 2010Pharmacogenetics and GenomicsOpen Access

VKORC1 Pharmacogenomics Summary

View Full Paper

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Abstract

Owen, Ryan P.; Gong, Li; Sagreiya, Hersh; Klein, Teri E.; Altman, Russ B. Author Information

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Owen et al. (2010) studied this question.

synapsesocial.com/papers/6a6faf33e36a167817e16516 https://doi.org/10.1097/fpc.0b013e32833433b6

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1The influence of sequence variations in factor VII, γ-glutamyl carboxylase and vitamin K epoxide reductase complex genes on warfarin dose requirementOriginal Research · 2006 · 121 citations
2Use of Pharmacogenetic and Clinical Factors to Predict the Therapeutic Dose of WarfarinCohort Study · 2008 · 838 citations
3Engineering of a Recombinant Vitamin K-dependent γ-Carboxylation System with Enhanced γ-Carboxyglutamic Acid Forming CapacityOriginal Research · 2005 · 72 citations
4VKORC1 haplotypes and their impact on the inter-individual and inter-ethnical variability of oral anticoagulationOriginal Research · 2005 · 258 citations
5Effect of <i>VKORC1</i> Haplotypes on Transcriptional Regulation and Warfarin DoseRetrospective Study · 2005 · 1,401 citations